XML 38 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Data
 3 Months Ended
Jun. 30, 2012
Segment Data  
Segment Data

10.  Segment Data

 

Our operations are organized into two reporting segments:  Biological Indicators and Instruments.  The following tables set forth our segment information:

 

(Dollars in thousands)

 

Biological
Indicators

 

Instruments

 

Total

 

Three months ended June 30, 2012

 

 

 

 

 

 

 

Revenue

 

$

5,118

 

$

5,441

 

$

10,559

 

Operating Income

 

1,449

 

1,770

 

3,219

 

Other (Income) and Expense

 

(2

)

36

 

34

 

Capital Expenditures

 

33

 

152

 

185

 

Bios Acquisition.

 

—

 

18,900

 

18,900

 

Depreciation

 

128

 

75

 

203

 

Amortization

 

403

 

178

 

581

 

 

 

 

 

 

 

 

 

Three months ended June 30, 2011

 

 

 

 

 

 

 

Revenue

 

$

4,668

 

$

4,629

 

$

9,297

 

Operating Income

 

941

 

1,752

 

2,693

 

Other (Income) and Expense

 

53

 

(3

)

50

 

Capital Expenditures

 

125

 

62

 

187

 

Depreciation

 

113

 

52

 

165

 

Amortization

 

336

 

40

 

376

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

 

 

June 30, 2012

 

$

31,077

 

$

35,634

 

$

66,711

 

March 31, 2012

 

32,915

 

17,781

 

50,696

 

 

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows:

 

 

 

Three months ended
June 30,

 

(Dollars in thousands)

 

2012

 

2011

 

Net revenues from unaffiliated customers:

 

 

 

 

 

United States

 

$

6,369

 

$

5,746

 

Foreign (no country exceeds 10% of total)

 

4,190

 

3,551

 

 

 

$

10,559

 

$

9,297

 

 

All long-lived assets are located in the United States.